{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:36:51Z","timestamp":1784248611177,"version":"3.55.0"},"reference-count":66,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CBM"],"published-print":{"date-parts":[[2021,9,24]]},"abstract":"<jats:p>BACKGROUND: Penile cancer (PeCa) is a rare disease, but its incidence has increased worldwide, mostly in HPV+ patients. Nevertheless, there is still no targeted treatment for this carcinoma. OBJECTIVE: To predict the main signaling pathways involved in penile tumorigenesis and its potential drug targets. METHODS: Genome-wide copy number profiling was performed in 28 PeCa. Integration analysis of CNAs and miRNAs and mRNA targets was performed by DIANA-TarBase v.8. The potential impact of the miRNAs\/target genes on biological pathways was assessed by DIANA-miRPath v.3.0. For each miRNA, KEGG pathways were generated based on the tarbase and microT-CDS algorithms. Pharmaco-miR was used to identify associations between miRNAs and their target genes to predict druggable targets. RESULTS: 269 miRNAs and 2,395 genes were mapped in cytobands with CNAs. The comparison of the miRNAs mapped at these cytobands and the miRNAs that were predicted to regulate the genes also mapped in these regions, resulted in a set of common 35 miRNAs and 292 genes. Enrichment pathway revealed their involvement in five top signaling pathways. EGFR and COX2 were identified as potential druggable targets. CONCLUSION: Our data indicate the potential use of EGFR and COX2 inhibitors as a target treatment for PeCa patients.<\/jats:p>","DOI":"10.3233\/cbm-210035","type":"journal-article","created":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T13:52:06Z","timestamp":1623765126000},"page":"147-160","source":"Crossref","is-referenced-by-count":8,"title":["HPV-associated penile cancer: Impact of copy number alterations in miRNA\/mRNA interactions and potential druggable targets"],"prefix":"10.1177","volume":"32","author":[{"given":"Jenilson da","family":"Silva","sequence":"first","affiliation":[{"name":"Postgraduate Program in Health Science, Federal University of Maranh\u00e3o, S\u00e3o Lu\u00eds, MA, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leudivan","family":"Nogueira","sequence":"additional","affiliation":[{"name":"Postgraduate Program in Health Science, Federal University of Maranh\u00e3o, S\u00e3o Lu\u00eds, MA, Brazil"},{"name":"Aldenora Bello Cancer Hospital, S\u00e3o Lu\u00eds, MA, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Coelho","sequence":"additional","affiliation":[{"name":"Aldenora Bello Cancer Hospital, S\u00e3o Lu\u00eds, MA, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Deus","sequence":"additional","affiliation":[{"name":"Postgraduate Program in Health Science, Federal University of Maranh\u00e3o, S\u00e3o Lu\u00eds, MA, Brazil"},{"name":"Aldenora Bello Cancer Hospital, S\u00e3o Lu\u00eds, MA, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Khayat","sequence":"additional","affiliation":[{"name":"Oncology Research Center, Federal University of Par\u00e1, Bel\u00e9m, PA, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Marchi","sequence":"additional","affiliation":[{"name":"Research Institute Pel\u00e9 Pequeno Pr\u00edncipe, Faculdades Pequeno Pr\u00edncipe, Curitiba, PR, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edivaldo de","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Tissue Culture and Cytogenetics Laboratory, Institute of Evandro Chagas, Bel\u00e9m, PA, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula dos","family":"Santos","sequence":"additional","affiliation":[{"name":"Department of Physiological Sciences, Federal University of Maranh\u00e3o, S\u00e3o Lu\u00eds, MA, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciane","family":"Cavalli","sequence":"additional","affiliation":[{"name":"Research Institute Pel\u00e9 Pequeno Pr\u00edncipe, Faculdades Pequeno Pr\u00edncipe, Curitiba, PR, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silma","family":"Pereira","sequence":"additional","affiliation":[{"name":"Laboratory of Genetics and Molecular Biology, Department of Biology, Federal University of Maranh\u00e3o, S\u00e3o Lu\u00eds, MA, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/CBM-210035_ref1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12894-018-0365-0","article-title":"Penile cancer in Maranho, Northeast Brazil: The highest incidence globally","volume":"18","author":"Coelho","year":"2018","journal-title":"BMC Urology"},{"key":"10.3233\/CBM-210035_ref2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/MOU.0000000000000581","article-title":"Penile cancer epidemiology and risk factors: A contemporary review","volume":"29","author":"Douglawi","year":"2019","journal-title":"Current Opinion in Urology"},{"key":"10.3233\/CBM-210035_ref3","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ijid.2018.11.003","article-title":"Etiological role of human papillomavirus infection in the development of penile cancer","volume":"78","author":"Sakamoto","year":"2019","journal-title":"International Journal of Infectious Diseases"},{"key":"10.3233\/CBM-210035_ref4","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/mc.23185","article-title":"Genomic profiling reveals the pivotal role of hrHPV driving copy number and gene expression alterations, including mRNA downregulation of TP53 and RB1 in penile cancer","volume":"59","author":"Macedo","year":"2020","journal-title":"Molecular Carcinogenesis"},{"key":"10.3233\/CBM-210035_ref5","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/j.juro.2017.01.059","article-title":"Penile cancer: Contemporary lymph node management","volume":"197","author":"O\u2019Brien","year":"2017","journal-title":"Journal of Urology"},{"key":"10.3233\/CBM-210035_ref6","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.clgc.2017.02.002","article-title":"Clinical outcomes of patients with locally advanced penile squamous-cell carcinoma: Results of a multicenter analysis","volume":"15","author":"Necchi","year":"2017","journal-title":"Clinical Genitourinary Cancer"},{"key":"10.3233\/CBM-210035_ref7","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/j.juro.2017.01.059","article-title":"Penile cancer: Contemporary lymph node management","volume":"197","author":"O\u2019Brien","year":"2017","journal-title":"Journal of Urology"},{"key":"10.3233\/CBM-210035_ref8","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3238\/arztebl.2018.0646","article-title":"The diagnosis and treatment of penile cancer","volume":"115","author":"Hakenberg","year":"2018","journal-title":"Deutsches Aerzteblatt Online"},{"key":"10.3233\/CBM-210035_ref9","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/bju.12946","article-title":"Prognostic factors influencing survival from regionally advanced squamous cell carcinoma of the penis after preoperative chemotherapy","volume":"117","author":"Dickstein","year":"2016","journal-title":"BJU International"},{"key":"10.3233\/CBM-210035_ref10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-019-5847-2","article-title":"Neoadjuvant docetaxel, cisplatin and ifosfamide (ITP) combination chemotherapy for treating penile squamous cell carcinoma patients with terminal lymph node metastasis","volume":"19","author":"Xu","year":"2019","journal-title":"BMC Cancer"},{"key":"10.3233\/CBM-210035_ref11","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s12282-017-0814-8","article-title":"Candidate miRNAs in human breast cancer biomarkers: A systematic review","volume":"25","author":"Adhami","year":"2018","journal-title":"Breast Cancer"},{"key":"10.3233\/CBM-210035_ref12","doi-asserted-by":"publisher","first-page":"5989","DOI":"10.2174\/1381612823666170714151715","article-title":"MiRNA-based therapeutics for lung cancer","volume":"23","author":"Wu","year":"2018","journal-title":"Current Pharmaceutical Design"},{"key":"10.3233\/CBM-210035_ref13","doi-asserted-by":"publisher","first-page":"840","DOI":"10.3390\/cells8080840","article-title":"Role of miRNA-regulated cancer stem cells in the pathogenesis of human malignancies","volume":"8","author":"Khan","year":"2019","journal-title":"Cells"},{"key":"10.3233\/CBM-210035_ref14","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1073\/pnas.0307323101","article-title":"Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers","volume":"101","author":"Calin","year":"2004","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.3233\/CBM-210035_ref15","doi-asserted-by":"publisher","first-page":"9136","DOI":"10.1073\/pnas.0508889103","article-title":"microRNAs exhibit high frequency genomic alterations in human cancer","volume":"103","author":"Zhang","year":"2006","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.3233\/CBM-210035_ref16","doi-asserted-by":"publisher","DOI":"10.1038\/srep11567"},{"key":"10.3233\/CBM-210035_ref17","doi-asserted-by":"publisher","DOI":"10.1038\/sigtrans.2015.4"},{"key":"10.3233\/CBM-210035_ref18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers10120475","article-title":"Identification and characterization of microRNAs associated with somatic copy number alterations in cancer","volume":"10","author":"Soh","year":"2018","journal-title":"Cancers"},{"key":"10.3233\/CBM-210035_ref19","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/nar\/gky1141","article-title":"MiRBase: From microRNA sequences to function","volume":"47","author":"Kozomara","year":"2019","journal-title":"Nucleic Acids Research"},{"key":"10.3233\/CBM-210035_ref20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep12522","article-title":"HPVbase\u00a0\u2013 A knowledgebase of viral integrations, methylation patterns and microRNAs aberrant expression: As potential biomarkers for Human papillomaviruses mediated carcinomas","volume":"5","author":"Kumar\u00a0Gupta","year":"2015","journal-title":"Scientific Reports"},{"key":"10.3233\/CBM-210035_ref21","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/nar\/gkx1141","article-title":"DIANA-TarBase v8: A decade-long collection of experimentally supported miRNA-gene interactions","volume":"46","author":"Karagkouni","year":"2018","journal-title":"Nucleic Acids Research"},{"key":"10.3233\/CBM-210035_ref22","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1093\/nar\/gkv403","article-title":"DIANA-miRPath v3.0: Deciphering microRNA function with experimental support","volume":"43","author":"Vlachos","year":"2015","journal-title":"Nucleic Acids Research"},{"key":"10.3233\/CBM-210035_ref23","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1093\/bib\/bbs082","article-title":"Pharmaco-miR: Linking microRNAs and drug effects","volume":"15","author":"Rukov","year":"2013","journal-title":"Briefings in Bioinformatics"},{"key":"10.3233\/CBM-210035_ref24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pcbi.1004085","article-title":"PathVisio 3: An extendable pathway analysis toolbox","volume":"11","author":"Kutmon","year":"2015","journal-title":"PLoS Computational Biology"},{"key":"10.3233\/CBM-210035_ref25","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1158\/1940-6207.CAPR-14-0284","article-title":"Genomic profiling of human penile carcinoma predicts worse prognosis and survival","volume":"8","author":"Busso-Lopes","year":"2014","journal-title":"Cancer Prevention Research"},{"key":"10.3233\/CBM-210035_ref26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0146740","article-title":"DNA copy number aberrations, and human papillomavirus status in penile Carcinoma. Clinico-pathological correlations and potential driver genes","volume":"11","author":"La-Touche","year":"2016","journal-title":"PLoS ONE"},{"key":"10.3233\/CBM-210035_ref27","doi-asserted-by":"crossref","first-page":"15294","DOI":"10.18632\/oncotarget.14783","article-title":"Integrative miRNA and mRNA analysis in penile carcinomas reveals markers and pathways with potential clinical impact","volume":"8","author":"Kuasne","year":"2017","journal-title":"Oncotarget"},{"key":"10.3233\/CBM-210035_ref28","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1002\/ijc.32373","article-title":"Mutational landscape of penile squamous cell carcinoma in a Chinese population","volume":"145","author":"Wang","year":"2019","journal-title":"International Journal of Cancer"},{"issue":"2016","key":"10.3233\/CBM-210035_ref29","doi-asserted-by":"publisher","first-page":"4720","DOI":"10.1158\/0008-5472.CAN-15-3134","article-title":"CSN1 somatic mutations in penile squamous cell carcinoma","volume":"76","author":"Feber","journal-title":"Cancer Research"},{"key":"10.3233\/CBM-210035_ref30","doi-asserted-by":"publisher","first-page":"8877","DOI":"10.18632\/oncotarget.12830","article-title":"Next generation sequencing and its applications in HPV-associated cancers","volume":"8","author":"Tuna","year":"2017","journal-title":"Oncotarget"},{"key":"10.3233\/CBM-210035_ref31","doi-asserted-by":"publisher","first-page":"972","DOI":"10.3390\/cells9040972","article-title":"The YAP\/TAZ pathway in osteogenesis and bone sarcoma pathogenesis","volume":"9","author":"Kovar","year":"2020","journal-title":"Cells"},{"key":"10.3233\/CBM-210035_ref32","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.3892\/mmr.2018.9215","article-title":"MicroRNA expression profiles identify biomarkers for predicting the response to chemoradiotherapy in rectal cancer","volume":"18","author":"Du","year":"2018","journal-title":"Molecular Medicine Reports"},{"key":"10.3233\/CBM-210035_ref33","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.3892\/mmr.2018.9312","article-title":"Screening of exosomal miRNAs derived from subcutaneous and visceral adipose tissues: Determination of targets for the treatment of obesity and associated metabolic disorders","volume":"18","author":"Yang","year":"2018","journal-title":"Molecular Medicine Reports"},{"key":"10.3233\/CBM-210035_ref34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-018-0871-4","article-title":"The chromosome 11q13.3 amplification associated lymph node metastasis is driven by miR-548k through modulating tumor microenvironment","volume":"17","author":"Zhang","year":"2018","journal-title":"Molecular Cancer"},{"key":"10.3233\/CBM-210035_ref35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ncrna.2019.12.002","article-title":"Unravelling the role of long non-coding RNA\u00a0\u2013 LINC01087 in breast cancer","volume":"5","author":"Tripathi","year":"2020","journal-title":"Non-Coding RNA Research"},{"key":"10.3233\/CBM-210035_ref36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0042436","article-title":"TGF-beta induces serous borderline ovarian tumor cell invasion by activating EMT but triggers apoptosis in low-grade serous ovarian carcinoma cells","volume":"7","author":"Cheng","year":"2012","journal-title":"PLoS ONE"},{"key":"10.3233\/CBM-210035_ref37","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1158\/1078-0432.CCR-18-1726","article-title":"SMAD4 loss in colorectal cancer patients correlates with recurrence, loss of immune infiltrate, and chemoresistance","volume":"25","author":"Wasserman","year":"2018","journal-title":"Clinical Cancer Research"},{"key":"10.3233\/CBM-210035_ref38","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.molonc.2014.08.004","article-title":"BMPR2 loss in fibroblasts promotes mammary carcinoma metastasis via increased inflammation","volume":"9","author":"Pickup","year":"2015","journal-title":"Molecular Oncology"},{"key":"10.3233\/CBM-210035_ref39","doi-asserted-by":"publisher","first-page":"63110","DOI":"10.18632\/oncotarget.18668","article-title":"Epigenetic regulation of NOTCH1 and NOTCH3 by KMT2A inhibits glioma proliferation","volume":"8","author":"Huang","year":"2017","journal-title":"Oncotarget"},{"key":"10.3233\/CBM-210035_ref40","doi-asserted-by":"publisher","first-page":"94080","DOI":"10.18632\/oncotarget.21583","article-title":"SETD7 is a prognosis predicting factor of breast cancer and regulates redox homeostasis","volume":"8","author":"Huang","year":"2017","journal-title":"Oncotarget"},{"key":"10.3233\/CBM-210035_ref41","doi-asserted-by":"publisher","first-page":"43162","DOI":"10.18632\/oncotarget.6351","article-title":"SUV420H1 enhances the phosphorylation and transcription of ERK1 in cancer cells","volume":"6","author":"Vougiouklakis","year":"2015","journal-title":"Oncotarget"},{"key":"10.3233\/CBM-210035_ref42","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.2147\/OTT.S191732","article-title":"Downregulation of NSD3 (WHSC1L1) inhibits cell proliferation and migration via ERK1\/2 deactivation and decreasing CAPG expression in colorectal cancer cells","volume":"12","author":"Yi","year":"2019","journal-title":"OncoTargets and Therapy"},{"key":"10.3233\/CBM-210035_ref43","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.bbrc.2018.08.143","article-title":"Downregulation of KMT2D suppresses proliferation and induces apoptosis of gastric cancer","volume":"504","author":"Xiong","year":"2018","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.3233\/CBM-210035_ref44","first-page":"1739","article-title":"The O-glycosylating enzyme GALNT2 suppresses the malignancy of gastric adenocarcinoma by reducing EGFR activities","volume":"8","author":"Hu","year":"2018","journal-title":"American Journal of Cancer Research"},{"key":"10.3233\/CBM-210035_ref45","doi-asserted-by":"publisher","first-page":"11251","DOI":"10.18632\/oncotarget.7081","article-title":"Mucin glycosylating enzyme GALNT2 suppresses malignancy in gastric adenocarcinoma by reducing MET phosphorylation","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"10.3233\/CBM-210035_ref46","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ccr.2011.05.027","article-title":"miR-30b\/30d Regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis","volume":"20","author":"Gaziel-Sovran","year":"2011","journal-title":"Cancer Cell"},{"key":"10.3233\/CBM-210035_ref47","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1038\/bjc.2016.116","article-title":"Loss of N-acetylgalactosaminyltransferase 3 in poorly differentiated pancreatic cancer: Augmented aggressiveness and aberrant ErbB family glycosylation","volume":"114","author":"Chugh","year":"2016","journal-title":"British Journal of Cancer"},{"key":"10.3233\/CBM-210035_ref48","doi-asserted-by":"publisher","first-page":"313","DOI":"10.4062\/biomolther.2017.033","article-title":"Cellular prion protein enhances drug resistance of colorectal cancer cells via regulation of a survival signal pathway","volume":"26","author":"Lee","year":"2018","journal-title":"Biomolecules and Therapeutics"},{"key":"10.3233\/CBM-210035_ref49","doi-asserted-by":"publisher","first-page":"18747","DOI":"10.1074\/jbc.M117.787283","article-title":"Prion protein is required for tumor necrosis factor \u03b1 (TNF\u03b1)-triggered nuclear factor \u03bab (NF-\u03baB) signaling and cytokine production","volume":"292","author":"Wu","year":"2017","journal-title":"Journal of Biological Chemistry"},{"key":"10.3233\/CBM-210035_ref50","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/1878-0261.12411","article-title":"EGFR and Prion protein promote signaling via FOXO3a-KLF5 resulting in clinical resistance to platinum agents in colorectal cancer","volume":"13","author":"Atkinson","year":"2019","journal-title":"Molecular Oncology"},{"key":"10.3233\/CBM-210035_ref51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2018.00069","article-title":"Proteoglycans-Biomarkers and targets in cancer therapy","volume":"9","author":"Nikitovic","year":"2018","journal-title":"Frontiers in Endocrinology"},{"key":"10.3233\/CBM-210035_ref52","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1128\/AAC.02284-13","article-title":"Inhibition by cellular vacuolar atpase impairs human papillomavirus uncoating and infection","volume":"58","author":"Mller","year":"2014","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.3233\/CBM-210035_ref53","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13027-018-0208-3","article-title":"Human papillomavirus E5 protein, the undercover culprit of tumorigenesis","volume":"13","author":"Hemmat","year":"2018","journal-title":"Infectious Agents and Cancer"},{"key":"10.3233\/CBM-210035_ref54","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.virol.2013.05.006","article-title":"The E5 proteins","volume":"445","author":"DiMaio","year":"2013","journal-title":"Virology"},{"key":"10.3233\/CBM-210035_ref55","doi-asserted-by":"publisher","first-page":"5839","DOI":"10.1128\/jvi.79.9.5839-5846.2005","article-title":"Endoplasmic reticulum-localized human papillomavirus type 16 E5 protein alters endosomal pH but not trans-Golgi pH","volume":"79","author":"Disbrow","year":"2005","journal-title":"Journal of Virology"},{"key":"10.3233\/CBM-210035_ref56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.22693","article-title":"The vacuolar-ATPase complex and assembly factors, TMEM199 and CCDC115, control HIF1\u03b1 prolyl hydroxylation by regulating cellular Iron levels","volume":"6","author":"Miles","year":"2017","journal-title":"ELife"},{"key":"10.3233\/CBM-210035_ref57","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1038\/s41598-017-02831-9","article-title":"Human papilloma virus E7 oncoprotein abrogates the p53-p21-DREAM pathway","volume":"7","author":"Fischer","year":"2017","journal-title":"Scientific Reports"},{"key":"10.3233\/CBM-210035_ref58","doi-asserted-by":"publisher","first-page":"814","DOI":"10.3390\/cells10040814","article-title":"Penile cancer-derived cells molecularly characterized as models to guide targeted therapies","volume":"10","author":"Kuasne","year":"2021","journal-title":"Cells"},{"key":"10.3233\/CBM-210035_ref59","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1021\/acs.molpharmaceut.7b00308","article-title":"Cetuximab prevents methotrexate-induced cytotoxicity in vitro through epidermal growth factor dependent regulation of renal drug transporters","volume":"14","author":"Caetano-Pinto","year":"2017","journal-title":"Molecular Pharmaceutics"},{"key":"10.3233\/CBM-210035_ref60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta14suppl1\/01","article-title":"Cetuximab for the first-line treatment of metastatic colorectal cancer","volume":"1","author":"Meads","year":"2010","journal-title":"Health Technology Assessment"},{"key":"10.3233\/CBM-210035_ref61","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.ejca.2012.02.057","article-title":"Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: Pooled analysis of the CRYSTAL and OPUS randomised clinical trials","volume":"48","author":"Bokemeyer","year":"2012","journal-title":"European Journal of Cancer"},{"key":"10.3233\/CBM-210035_ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.anl.2020.07.002"},{"key":"10.3233\/CBM-210035_ref63","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1200\/JCO.2018.78.3183","article-title":"Efficacy and tolerability of first-line cetuximab plus leucovorin, fluorouracil, and oxaliplatin (FOLFOX-4) versus FOLFOX-4 in patientswith RASwild-typemetastatic colorectal cancer: The open-label, randomized, phase III TAILOR trial","volume":"36","author":"Qin","year":"2018","journal-title":"Journal of Clinical Oncology"},{"key":"10.3233\/CBM-210035_ref64","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2020.06.001"},{"key":"10.3233\/CBM-210035_ref65","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1080\/10520295.2019.1700429","article-title":"Combination of celecoxib and calyculin-A inhibits epithelial-mesenchymal transition in human oral cancer cells","volume":"95","author":"Velmurugan","year":"2020","journal-title":"Biotechnic and Histochemistry"},{"key":"10.3233\/CBM-210035_ref66","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.3390\/cancers12051117","article-title":"Celecoxib prevents doxorubicin-induced multidrug resistance in canine and mouse lymphoma cell lines","volume":"12","author":"Karai","year":"2020","journal-title":"Cancers"}],"container-title":["Cancer Biomarkers"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/CBM-210035","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:08:17Z","timestamp":1777385297000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/CBM-210035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,24]]},"references-count":66,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/cbm-210035","relation":{},"ISSN":["1875-8592","1574-0153"],"issn-type":[{"value":"1875-8592","type":"electronic"},{"value":"1574-0153","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,24]]}}}